Johnson & Johnson is trimming its sales force for anemia drug Procrit, a top-seller that has lost market share recently due to increased competition from Amgen’s Aranesp. Ortho Biotech Products, the J ...
Hospitals and pharmacies may have unknowingly bought a counterfeit version of the anti-anemia drug Procrit — and the useless product also is contaminated with bacteria, the government warned Tuesday.
Dec. 9, 2004 -- The U.S. Food and Drug Administration (FDA) and Ortho Biotech Products warned healthcare professionals via letter of important information regarding the safe dosing of epoetin alfa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback